Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

ACUTE rheumatic fever, in the absence of intercurrent streptococcal respiratory infections and rheumatic recrudescences, is generally a self-limited disease that subsides within twelve weeks.

Rheumatic heart disease is a chronic condition that results years after acute rheumatic fever, which is caused by group A beta-hemolytic Streptococcus pyogenes. This organism produces a ...

The historical record shows that the battle to prevent and find cures for infectious disease will lead to a lower incidence ...

Health's content is for informational and educational purposes only. Our website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Health is part of the ...

The following is a summary of “Development of START, a novel multimedia-based symptom appraisal tool for autoimmune rheumatic ...

Rheumatic heart disease (RHD) constitutes a leading cause of premature death and incapacity in Africa, where it is encountered in younger people, and shows a much faster and more serious course ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

The research of the Helsinki Rheumatic diseases and Inflammation Group focuses on studying the mechanisms of inflammation in rheumatic diseases and osteoarthritis, with special emphasis on role of ...